Vijaypd Ceutical Ltd (VIJAYPD) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Vijaypd Ceutical Ltd on NSE and BSE, with an AI summary of each filing.
Vijaypd Ceutical Limited has informed the Exchange regarding Outcome of Board Meeting held on October 26, 2026.
Outcome · 27 Oct 2026, 12:04 am
Vijaypd Ceutical Board Approves Alteration in MOA Main Object Clause Vijaypd Ceutical Limited announced that its Board of Directors approved an alteration to the Main Object clause of the company's Memorandum of Association (MOA) at its meeting held on 26th Oct'26. Additionally, the Board approved the cut-off date to determine member eligibility for voting on postal ballot resolutions and appointed M/s. Nikunj Kanabar & Associates, Practicing Company Secretaries, as the scrutinizer to oversee the postal ballot voting process.
Vijaypd Ceutical Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the 30th September, 2026
Others (Uncategorized) · 12 Oct 2026, 3:07 am
Vijaypd Ceutical Reports Non-Applicability of Corporate Governance Compliance for Sep'26 Quarter Vijaypd Ceutical Ltd. announced that Regulation 27(2) regarding the submission of the quarterly Corporate Governance Report is not applicable to the company for the quarter ended 30th Sep'26. The exemption falls under Regulation 15 of SEBI LODR Regulations, 2015, as the company’s securities are listed on the NSE EMERGE SME platform. Additionally, the company affirmed that it will comply with relevant corporate governance provisions within six months should they become applicable at a later date.
Vijaypd Ceutical Limited has informed the Exchange about Appointment of Investor Relations (IR) agency
Others (Uncategorized) · 06 Oct 2026, 1:57 am
Vijaypd Ceutical Appoints Finportal Investments as Investor Relations Advisory Agency Vijaypd Ceutical Limited has appointed Finportal Investments Private Limited as its Investor Relations (IR) agency to provide IR advisory services, effective 5th Oct'26. The intimation was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Vijaypd Ceutical Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 02 Oct 2026, 8:29 pm
Vijaypd Ceutical Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
Annual General Meeting · 01 Oct 2026, 1:09 am
Vijaypd Ceutical Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Technical Business Collaboration with Acute Research Private Limited'.
Others (Uncategorized) · 18 Sept 2026, 6:35 pm
VijayPD Ceutical Partners with Acute Research for Technical and R&D Support VijayPD Ceutical Limited entered into a Technical Business Collaboration with Acute Research Private Limited on 18th Sep'26. Under the pact, Acute Research will provide end-to-end scientific, technical, and R&D support for VijayPD's pharmaceutical and specialty chemical business. The scope encompasses API and intermediate R&D, synthetic route selection, process optimization, pilot trials, technology transfer to commercial plants, analytical validation, regulatory documentation (including DMFs), and audit support, significantly bolstering the company's product development and commercialization capabilities.
Vijaypd Ceutical Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Annual General Meeting · 05 Sept 2026, 3:02 am
Vijaypd Ceutical Limited has informed the Exchange regarding Outcome of Board Meeting held on August 29, 2026.
Outcome · 29 Aug 2026, 6:48 pm
Vijaypdceutical Board Approves AGM, Appoints Secretarial Auditor for FY27 Vijaypdceutical's board, in its meeting on 29 Aug'26, approved the notice for its 2nd Annual General Meeting and the Director's Report for the year ended 31 Mar'26. A cut-off date was fixed to determine voting eligibility. Key approvals include the appointment of M/s. Nikunj Kanabar & Associates as Scrutinizer for the AGM and as the Secretarial Auditor for the financial year 2026-27. The newly appointed auditor is a Mumbai-based firm with over eight years of experience and is not related to the company's directors.
Vijaypd Ceutical Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt of Expression of Interest for API Contract Manufacturing Business'.
Others (Uncategorized) · 26 Aug 2026, 7:50 pm
VijayPD Ceutical Receives EOI for API Export Contract Manufacturing On 26th Aug'26, VijayPD Ceutical Ltd. received an Expression of Interest (EOI) from Squadron Pharmaceuticals LLP for a potential business association. The proposal involves contract manufacturing of Active Pharmaceutical Ingredients (APIs) specifically for export markets. Products under consideration include Sitagliptin, Apixaban, and Rivaroxaban. The objective is to expand VijayPD's API manufacturing business and strengthen its export presence. The financial impact is currently unquantified as the proposal is at an exploratory stage, with commercial terms yet to be finalized.
Vijaypd Ceutical Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Quater ended 30th June 2026
Others (Uncategorized) · 03 Jul 2026, 10:00 pm
Vijaypdceutical Claims Exemption from Corporate Governance Reporting for Q1FY27 Vijaypdceutical Ltd. (VIJAYPD) has informed the exchange on 3rd Jul'26 that it is not required to submit the Corporate Governance Report for the quarter ended 30th Jun'26. The company claims exemption under SEBI's Regulation 15, citing its listing on the NSE EMERGE (SME) platform. This regulation exempts entities listed on SME exchanges from complying with specified corporate governance provisions. The company undertakes to comply within six months should the regulations become applicable in the future.
The Exchange had sought clarification from Vijaypd Ceutical Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Half Yearly figures not submitted by the Company The response of the Company is enclosed.
Others (Uncategorized) · 01 Jul 2026, 4:39 pm
Vijaypd Ceutical Submits Revised Consolidated Results for Half Year Ended Mar'26 Vijaypd Ceutical submitted revised financials for the half-year and full-year ended 31-Mar'26, following an NSE query about missing consolidated figures. For FY26, consolidated net profit stood at Rs. 500.10 lakhs on revenue of Rs. 10,023.36 lakhs, with an EPS of Rs. 3.00. The results include financials from subsidiary Zen Pharmaceuticals, acquired on 01-Dec'25. The company raised Rs. 1,925 lakhs via IPO in Sep'25, of which Rs. 855.75 lakhs remains unutilized and is held in deposits/bank accounts.